BIOE (Bio Essence) Short-Term Debt: $0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOE Bio Essence Corp BIOE
35 GF Score
Price $0.25
! 2 Warning Signs
View Full Analysis

What is Bio Essence Short-Term Debt?

Bio Essence BIOE 35 Short-Term Debt is $0.00 Mil as of Jun. 2026. GuruFocus rates BIOE with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

Bio Essence's Short-Term Debt for the quarter that ended in Jun. 2026 was $0.00 Mil.

Bio Essence's quarterly Short-Term Debt declined from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.00 Mil) but then stayed the same from Mar. 2026 ($0.00 Mil) to Jun. 2026 ($0.00 Mil).

Bio Essence's annual Short-Term Debt declined from Dec. 2023 ($1.80 Mil) to Dec. 2024 ($1.19 Mil) and declined from Dec. 2024 ($1.19 Mil) to Dec. 2025 ($0.00 Mil).

Bio Essence Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bio Essence Short-Term Debt Related Terms

Bio Essence Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Bio Essence's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Essence Short-Term Debt Chart

Bio Essence Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial 2.43 3.22 1.80 1.19 0.00

Bio Essence Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 0.89 0.00 0.00 0.00
BIOE
35GF Score
Bio Essence Corp BIOE
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $0.00 Mil mean?
Bio Essence (BIOE) has a Short-Term Debt of $0.00 Mil as of Jun. 2026.
Is Bio Essence's Short-Term Debt too high?
Bio Essence's current Short-Term Debt is $0.00 Mil. Overall, Bio Essence has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Bio Essence's Short-Term Debt compare to IGPK and CABR?
Bio Essence's Short-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Drug Manufacturers company?
A good Short-Term Debt depends on the Drug Manufacturers industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Bio Essence's current Short-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Essence stock overvalued right now?
Bio Essence (BIOE) has a current Short-Term Debt of $0.00 Mil. The current Short-Term Debt is $0.00 Mil. Bio Essence's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Bio Essence (BIOE), the current Short-Term Debt is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Essence Business Description

Address 2955 Main Street, Suite 300, Irvine, CA, USA, 92618
Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The primary focus of BEP was producing products for BEH and McBE, along with providing original equipment manufacturing and private label services to other companies. BEH targeted and developed traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. It also offered specially formulated dietary supplements and medical food. The Company operates in one business and industry segment: the manufacture / OEM and sale of health supplement products. The group's products are RED Yeast Rice Plus, Regenva, MediDrink, and Nufargo.
35GF Score

Get the complete analysis for BIOE

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price